CD274 and hepatocellular carcinoma: Fortunately, with the in-depth research on PD-1/PD-L1 inhibitors and targeted drugs, an increasing number of combination therapy strategies have been widely used in the first-line treatment of unresectable or advanced HCC, which can effectively improve the PFS and OS of patients with HCC.